We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 17, 2020

Pegaspargase With Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

The Oncologist

 

Additional Info

The Oncologist
Pegaspargase Combined With Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study
Oncologist 2020 Jul 06;[EPub Ahead of Print], H Wang, L Wang, C Li, Z Wuxiao, G Chen, W Luo, Y Lu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading